How does a remote cancer second opinion from China work?

Five steps: (1) you submit pathology, imaging (DICOM), prior treatment summary and current medication list; (2) a Chinese radiologist re-reads the imaging; (3) a senior oncologist (主任医师, chief physician) reviews the entire case; (4) you have a 60-minute video consultation with the oncologist + interpreter; (5) you receive a written second-opinion report in English and Chinese covering diagnosis confirmation, staging review, treatment recommendations, and any clinical trial options. Standard turnaround 7–10 business days.

Why get a second opinion from a Chinese oncologist?

Three reasons: (1) China's top cancer centres see procedural volumes 3–10× larger than Western peers — a senior oncologist at Shanghai Cancer Center may have personally managed thousands of cases of your specific tumour subtype; (2) access to drugs, CAR-T products, proton centres and clinical trials not available in your home country; (3) candid, evidence-cited second opinion without referral politics. The cost ($800–$2,500) is a small fraction of the cost of treatment decisions made on incomplete information.

What does a Chinese second opinion typically reveal?

Common findings: (1) diagnostic refinement — molecular subtyping or staging reclassification that materially changes prognosis; (2) treatment alternatives — Chinese-approved drugs, CAR-T eligibility, proton candidacy, or clinical trial options unavailable at home; (3) cost-effective alternatives — comparable-efficacy domestic Chinese pharmaceuticals 30–50% cheaper than imported brands; (4) confirmation that your home plan is appropriate. The third and fourth outcomes are common — second opinion is not always disruptive.

Which oncologists provide second opinions through Panda Touring Care?

Senior oncologists (chief physician 主任医师 level, typically 20+ years experience) at: Shanghai Cancer Center (Fudan), 301 Hospital (PLA General), Cancer Hospital of CAMS (Beijing), Sun Yat-sen University Cancer Center (Guangzhou), and disease-specialised centres for less common tumour types (e.g. Wuwei Heavy Ion Center for sarcoma).

How much does a second opinion cost?

Standard package $800–$1,500 covering pathology + imaging review + 60-minute video consultation + bilingual written report. Complex cases requiring molecular diagnostics, multi-disciplinary review (e.g. tumour board) or expedited 5-day turnaround run $1,500–$2,500. Travel-to-China consultation packages (3-day on-site visit) start at $4,000 including coordinator and interpreter.

What documents do I need to submit?

Required: (1) pathology report (English or with translation); (2) imaging reports + DICOM files (CT, MRI, PET-CT); (3) prior treatment summary including chemo regimens, RT dose/fractionation, surgical notes; (4) current medication list; (5) most recent labs. Helpful: family history, genomic/NGS report if available, biomarker testing results. We accept everything via secure encrypted upload.

Can I follow through with treatment in China after a second opinion?

Yes. If the second opinion recommends treatment that is best delivered in China — e.g. CAR-T, proton therapy, integrative oncology, a clinical trial — Panda Touring Care arranges the full pathway: hospital admission, M-visa, accommodation, in-hospital interpretation, and 12-month remote follow-up after you return home.

Oncology · Remote second opinion

A second opinion from
China’s top oncologists.

Senior chief-physician review at Shanghai Cancer Center, 301 Hospital and other tier-1 Chinese centres. Imaging re-read, 60-minute video consult, bilingual written report. 7–10 days. $800–$2,500.

Request a second opinion Cancer hub

Process

Five steps to a written report.

Step 1

Submit records

Pathology, imaging (DICOM), prior treatment summary, medications. Secure encrypted upload via our patient portal. Allow 1 day for triage.

Step 2

Imaging re-read

A Chinese radiologist re-reads CT/MRI/PET-CT independently. Discrepancies with original report flagged. 2–3 business days.

Step 3

Oncologist review

Chief physician (主任医师) reviews complete case file. Develops written assessment + treatment recommendations. 3–4 business days.

Step 4

Video consultation

60-minute video call with oncologist + interpreter. You ask questions; they walk you through the recommendations. Recorded with your consent.

Step 5

Bilingual report

Final written report covering diagnosis confirmation, staging, treatment recommendations, clinical trial options, and (if relevant) Chinese hospital pathway.

FAQ

Second opinion service, answered.

How does a remote cancer second opinion from China work?: Five steps: (1) you submit pathology, imaging (DICOM), prior treatment summary and current medication list; (2) a Chinese radiologist re-reads the imaging; (3) a senior oncologist (主任医师, chief physician) reviews the entire case; (4) you have a 60-minute video consultation with the oncologist + interpreter; (5) you receive a written second-opinion report in English and Chinese covering diagnosis confirmation, staging review, treatment recommendations, and any clinical trial options. Standard turnaround 7–10 business days.
Why get a second opinion from a Chinese oncologist?: Three reasons: (1) China's top cancer centres see procedural volumes 3–10× larger than Western peers — a senior oncologist at Shanghai Cancer Center may have personally managed thousands of cases of your specific tumour subtype; (2) access to drugs, CAR-T products, proton centres and clinical trials not available in your home country; (3) candid, evidence-cited second opinion without referral politics. The cost ($800–$2,500) is a small fraction of the cost of treatment decisions made on incomplete information.
What does a Chinese second opinion typically reveal?: Common findings: (1) diagnostic refinement — molecular subtyping or staging reclassification that materially changes prognosis; (2) treatment alternatives — Chinese-approved drugs, CAR-T eligibility, proton candidacy, or clinical trial options unavailable at home; (3) cost-effective alternatives — comparable-efficacy domestic Chinese pharmaceuticals 30–50% cheaper than imported brands; (4) confirmation that your home plan is appropriate. The third and fourth outcomes are common — second opinion is not always disruptive.
Which oncologists provide second opinions through Panda Touring Care?: Senior oncologists (chief physician 主任医师 level, typically 20+ years experience) at: Shanghai Cancer Center (Fudan), 301 Hospital (PLA General), Cancer Hospital of CAMS (Beijing), Sun Yat-sen University Cancer Center (Guangzhou), and disease-specialised centres for less common tumour types (e.g. Wuwei Heavy Ion Center for sarcoma).
How much does a second opinion cost?: Standard package $800–$1,500 covering pathology + imaging review + 60-minute video consultation + bilingual written report. Complex cases requiring molecular diagnostics, multi-disciplinary review (e.g. tumour board) or expedited 5-day turnaround run $1,500–$2,500. Travel-to-China consultation packages (3-day on-site visit) start at $4,000 including coordinator and interpreter.
What documents do I need to submit?: Required: (1) pathology report (English or with translation); (2) imaging reports + DICOM files (CT, MRI, PET-CT); (3) prior treatment summary including chemo regimens, RT dose/fractionation, surgical notes; (4) current medication list; (5) most recent labs. Helpful: family history, genomic/NGS report if available, biomarker testing results. We accept everything via secure encrypted upload.
Can I follow through with treatment in China after a second opinion?: Yes. If the second opinion recommends treatment that is best delivered in China — e.g. CAR-T, proton therapy, integrative oncology, a clinical trial — Panda Touring Care arranges the full pathway: hospital admission, M-visa, accommodation, in-hospital interpretation, and 12-month remote follow-up after you return home.

Get clarity in
seven to ten days.

Submit your records via secure portal. A senior oncologist will review your complete case and return a candid, evidence-cited written report.

Submit case Treatment options

A second opinion fromChina’s top oncologists.